David J.B. Kim

Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test

Jorge D. Brioni, Alyssa B. O'Neill, David J.B. Kim et al. · European Journal of Pharmacology · 1993 · 216 citations

Psychiatry, Behavioral Neuroscience, Addiction +14

Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo

Clark A. Briggs, David J. Anderson, Jorge D. Brioni et al. · Pharmacology Biochemistry and Behavior · 1997 · 192 citations

Medicine, Nicotine, Receptor (Biochemistry) +6

Identification and Initial Structure−Activity Relationships of (<i>R</i>)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors

Mark W. Holladay, James T. Wasicak, Nan‐Horng Lin et al. · Journal of Medicinal Chemistry · 1998 · 131 citations · Full text

Pain Medicine, Neuropathic Pain, Orally Active +21

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A Novel, Orally Effective Antinociceptive Agent Acting via Neuronal Nicotinic Acetylcholine Receptors: II. In Vivo Characterization

Anthony W. Bannon, Michael Decker, Peter Curzon et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 77 citations

Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat

Peter Curzon, David J.B. Kim, Michael Decker · Pharmacology Biochemistry and Behavior · 1994 · 77 citations

Neurophysiology, Medicine, Nicotine +11